NEW YORK (GenomeWeb News) - Commonwealth Biotechnologies has agreed to buy Tripos Discovery Research from Tripos for $350,000 in cash up front and as much as $1.8 million more in follow-up receivables and billings from the TDR business, the companies said yesterday.
 
Commonwealth will continue to operate TDR from its Bude, UK, location.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.